18Sep
Government Continues to Closely Scrutinize Pharmaceutical Marketing Practices
On September 4, 2019 the Department of Justice (DOJ) announced a $15.4 million settlement with pharmaceutical company Mallinckrodt ARD LLC (Mallinckrodt) to resolve alleged violations of the Anti-Kickback Statute (AKS) in two whistleblower suits...
By:
Robinson+Cole Health Law Diagnosis
Related
The long wait is over. Today, the U.S. Department of Labor confirmed the final rule on the overtime ...
Read More >
The Legislative Assembly approved a reform to several provisions of the General Law of Concession of...
Read More >
The amended New Jersey WARN Act will impose significantly stricter obligations (including potential ...
Read More >
In today’s edition of Daily Compliance News: 1. Once a cheat, always a cheat? (NYT) 2. EY getting ...
Read More >
The #MeToo movement has brought public awareness to claims concerning pay disparity based on gender....
Read More >
After an M&A deal closes, the purchaser may discover information that it considers erroneous in the ...
Read More >